The EGFR-NSCLC Market was valued at USD 6762.75 million in the year 2022 and is expected to grow at a strong CAGR of around 6.7% during the forecast period (2023-2030). The region's emphasis on personalized medicine and precision oncology has fueled substantial investments in research and development, resulting in the emergence of innovative targeted therapies. The increasing availability of...